对性结肠炎的IBD-DCA的实施:一个机构的经验
David Egong1, Michéal Hanly2, Erinn McGrath3
1Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin, Ireland. david.egong@icloud.com.
Virchows Archiv : an international journal of pathology
|September 3, 2025
概括
炎症性肠病分布,慢性,活动 (IBD-DCA) 评分系统在性结肠炎 (UC) 活检中被广泛采用. 组织学活性与内学严重性相关,有助于临床试验应用.
科学领域:
- 胃肠病学
- 组织病理学
- 临床诊断
背景情况:
- 性结肠炎 (UC) 的诊断是复杂的,并影响患者的生活质量.
- 标准化报告对于一致的UC诊断和管理至关重要.
- 炎症性肠病分布,慢性,活动 (IBD-DCA) 评分系统是为UC的标准化结肠活检报告而开发的.
研究的目的:
- 评估特定部门内IBD-DCA评分系统的采用率.
- 将IBD-DCA系统的组织学发现与UC内镜严重性指数 (UCEIS) 相关联.
- 评估IBD-DCA系统在临床实践和未来研究中的有用性.
主要方法:
- 对449例炎症性肠病 (IBD) 活检进行了回顾,其中291例确诊UC病例.
- 分析不同活检部位的IBD-DCA报告格式的吸收率.
- 在116例UC病例中,Kendall的IBD- DCA之间的tau相关性分析报告了组织学活性和UCEIS得分.
主要成果:
- 在UC活检中,IBD-DCA报告格式的采用率超过95%.
- 在组织学活性 (IBD- DCA) 和UCEIS的所有成分之间观察到中度的正相关性 (τ > 0. 260, p < 0. 05).
- 在直肠活检中发现IBD- DCA系统的应用变化,并且发现了组织学和内镜之间的差异.
结论:
- IBD- DCA系统显示高吸收率,与UC中的内学严重程度有中等相关性.
- 组织学-内学差异可能来自采样差异或UCEIS的全结肠性质.
- 该研究倡导在临床试验中使用IBD-DCA来预测复发和治疗指导.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
206
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
206
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201
Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540


